License

Kiromic Announces License Agreement With Longwood University for chPD1

Biotechnology, Health, Genetics, Pharmaceutical, Oncology, Longwood, License
Tuesday, January 26, 2021 - 9:31pm

Kiromic BioPharma, Inc. (Nasdaq: KRBP), an immuno-oncology target discovery and gene-editing company, with a proprietary artificial intelligence neural network platform (Diamond AI) to develop novel oncology therapeutics, has announced the completion of the chPD1 licensing agreement with Longwood University.

Key Points: 
  • Kiromic BioPharma, Inc. (Nasdaq: KRBP), an immuno-oncology target discovery and gene-editing company, with a proprietary artificial intelligence neural network platform (Diamond AI) to develop novel oncology therapeutics, has announced the completion of the chPD1 licensing agreement with Longwood University.
  • "Longwood University is proud to have completed this chPD1 licensing agreement with Kiromic.
  • We believe that Kiromic has a strong Allogenic Off-The-Shelf CAR-T program which will be even stronger with chPD1.
  • "The completion of the licensing agreement for chPD1 marks a major milestone for Kiromic CAR-T development.

Silo Pharma Reaches Terms with University of Maryland Baltimore for Exclusive License of Central Nervous Homing Peptide for Neuroinflammatory Disease

Silo, Option, Silo, License, Patent, Articles, Retailers
Tuesday, January 26, 2021 - 1:18pm

The exercise of the option agreement allows for Silo to negotiate an exclusive patent license agreement.

Key Points: 
  • The exercise of the option agreement allows for Silo to negotiate an exclusive patent license agreement.
  • The option agreement included pre-negotiated business terms for the exclusive patent license, which we expect to finalize shortly.
  • Mr. Eric Weisblum, Chairman and CEO of Silo Pharma, commented, Silo is pleased to advance our research collaboration with UMB in the fight against Neuroinflammatory diseases.
  • Management looks forward to sharing the preclinical results of this Novel Homing Peptide upon completion of our initial study in connection with UMB."

ROCTOOL: High increase in turnover for S2: + 54 %

Articles, Strategic alliances, Intellectual property law, Human resource management, Industrial and organizational psychology, Turnover, Royalty payment, License
Thursday, January 14, 2021 - 12:19am

Licenses and royalties total 0.3 million , or -69% vs. 2019.

Key Points: 
  • Licenses and royalties total 0.3 million , or -69% vs. 2019.
  • As a reminder, 2019 included the renewal of a major license agreement signed with a long-standing customer of the company.
  • The medical sector confirms its potential by reaching 7% of turnover (vs 2% in 2019).
  • The consolidated results which will be published in March, despite a slightly lower turnover compared to 2019, should show a significant reduction in Roctool's losses in 2020.

Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications

Business law, License
Monday, January 11, 2021 - 1:30pm

The license agreement (the Agreement) with Aikido Pharma Inc., (Nasdaq:AIKI) a listed biotechnology company, grants Akido an exclusive, royalty-bearing license to certain intellectual property owned by Silo Pharma to develop therapeutics for the treatment and complications of cancer.

Key Points: 
  • The license agreement (the Agreement) with Aikido Pharma Inc., (Nasdaq:AIKI) a listed biotechnology company, grants Akido an exclusive, royalty-bearing license to certain intellectual property owned by Silo Pharma to develop therapeutics for the treatment and complications of cancer.
  • In consideration for granting the license, Silo Pharma received a one-time cash payment of $500,000 and shares of newly designated Convertible Preferred Stock valued at $500,000 on the date of execution of the license.
  • Silo Pharma will also be entitled to potential royalty payments on Net Sales (as defined in the Agreement) in the event that the licensed property is commercially developed.
  • Researching the use of psilocybin to treat both cancer and cancer side effects is a noteworthy opportunity for Silo Pharma and its shareholders.

Licensing Show and Conference held online next week

Hong Kong Trade Development Council, License, Hong Kong, Hong Kong Trade Development Council Trade Fairs
Friday, January 8, 2021 - 10:00am

The 19th HKTDC Hong Kong International Licensing Show (HKILS) and 10th Asian Licensing Conference (ALC), both organised by the Hong Kong Trade Development Council (HKTDC), will run from 11 to 15 January 2021 in a brand-new online format.

Key Points: 
  • The 19th HKTDC Hong Kong International Licensing Show (HKILS) and 10th Asian Licensing Conference (ALC), both organised by the Hong Kong Trade Development Council (HKTDC), will run from 11 to 15 January 2021 in a brand-new online format.
  • As the world's third-largest licensing market, Asia accounted for 12% of the global share of sales.
  • We expect that the Asian and mainland markets will continue to be growth engines for the licensing industry."
  • The "Licensing Academy" Channel will provide eight online workshop episodes targeting newcomers to the licensing field, covering some of the basic concepts of licensing such as IP protection and royalty fee management.

RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO INNOVAQOR, INC. (OTC: INOQ) [UPDATED]

Articles, Technology, Software testing, TPT, Unit testing, Science and technology, Telehealth, License
Wednesday, January 6, 2021 - 9:54pm

InnovaQor has previously completed a license agreement giving it certain rights to assets and technology from TPT Global Tech, Incs.

Key Points: 
  • InnovaQor has previously completed a license agreement giving it certain rights to assets and technology from TPT Global Tech, Incs.
  • As part of the License agreement InnovaQor and TPT have agreed a development project to create a next generation telehealth type platform.
  • Rennova has previously disclosed its intention to separate its technology and software divisions.
  • The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS OFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO INNOVAQOR, INC. (OTC: INOQ)

Articles, Technology, Software testing, TPT, Unit testing, Science and technology, Telehealth, License
Wednesday, January 6, 2021 - 2:20pm

InnovaQor has previously completed a license agreement giving it certain rights to assets and technology from TPT Global Tech, Incs.

Key Points: 
  • InnovaQor has previously completed a license agreement giving it certain rights to assets and technology from TPT Global Tech, Incs.
  • As part of the License agreement InnovaQor and TPT have agreed a development project to create a next generation telehealth type platform.
  • Rennova has previously disclosed its intention to separate its technology and software divisions.
  • The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

Irish touch and gesture technology licensor, Neodrón Limited, reaches settlement with top consumer electronics companies

Transducers, Capacitive sensing, License, Sensor, Technology, Computing, Articles
Tuesday, January 5, 2021 - 4:42pm

DUBLIN, Jan. 5, 2021 /PRNewswire/ -- Neodrn Limited ("Neodrn"), a leading Dublin, Ireland-based licensor of technology focused on the touch sensor market, announced today that it reached a settlement with ten of the world's largest consumer electronics companies.

Key Points: 
  • DUBLIN, Jan. 5, 2021 /PRNewswire/ -- Neodrn Limited ("Neodrn"), a leading Dublin, Ireland-based licensor of technology focused on the touch sensor market, announced today that it reached a settlement with ten of the world's largest consumer electronics companies.
  • The legal actions were brought by Neodrn beginning in 2019 in Germany, China, and the United States (including before the International Trade Commission).
  • This settlement further vindicates the strength and fundamental nature of the Neodrn patent portfolio.
  • Neodrn is a technology licensing company based in Dublin, Ireland covering capacitive touch sensors and touch controllers.

Irish touch and gesture technology licensor, Neodrón Limited, reaches settlement with top consumer electronics companies

Transducers, Capacitive sensing, License, Sensor, Technology, Computing, Articles
Tuesday, January 5, 2021 - 4:37pm

DUBLIN, Jan. 5, 2021 /PRNewswire/ -- Neodrn Limited ("Neodrn"), a leading Dublin, Ireland-based licensor of technology focused on the touch sensor market, announced today that it reached a settlement with ten of the world's largest consumer electronics companies.

Key Points: 
  • DUBLIN, Jan. 5, 2021 /PRNewswire/ -- Neodrn Limited ("Neodrn"), a leading Dublin, Ireland-based licensor of technology focused on the touch sensor market, announced today that it reached a settlement with ten of the world's largest consumer electronics companies.
  • The legal actions were brought by Neodrn beginning in 2019 in Germany, China, and the United States (including before the International Trade Commission).
  • This settlement further vindicates the strength and fundamental nature of the Neodrn patent portfolio.
  • Neodrn is a technology licensing company based in Dublin, Ireland covering capacitive touch sensors and touch controllers.

The Working Group structures $50 million stalking-horse license for intellectual property developed by Blackbird, preserves public use, auctions domains

Blackbird, Publishing software, Video editing software, Video hosting, Web hosting, License, World Wide Web, Royalty payment, Articles, Computing
Wednesday, December 23, 2020 - 6:08pm

NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) -- On November 30, 2020, The Working Group facilitated the license of technology developed by Blackbird Logical Applications, LLC (Blackbird) to Port.

Key Points: 
  • NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) -- On November 30, 2020, The Working Group facilitated the license of technology developed by Blackbird Logical Applications, LLC (Blackbird) to Port.
  • The Working Group represents the interests of Ilya Podolyako in debt and equity investments.
  • The license includes a royalty and a cash payment of up to $50 million in the event Port.
  • The license terminates in the event of non-use of the technology with an agreed upon period of time.